HealthcareNasdaq
Institutional-grade research for retail investors
SEC EDGAR: CIK 1834376INNV stock profile & AI dashboard →

13F Pro Quality Score

46.1/100

Rank #1,683 of 2,879 stocks

View Healthcare peers →

Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Aug 14, 2026.

Revenue Growth

71.7/100

Profitability

34.2/100

Balance Sheet

25.3/100

Earnings Quality

30.0/100

Free Cash Flow

53.0/100

Institutional Flow

29.2/100

Revenue Scale

48.3/100

Dilution Risk

60.2/100

INNV Stock Analysis & AI Quality Score

AI stock analysis and institutional research for InnovAge Holding Corp. (INNV), a Healthcare sector company. 13F Pro's AI-powered ranking engine scores INNV at 46.1/100 on a 32-signal composite quality model, placing it at rank #1,683 of 2,879 stocks — the bottom half of the AI-ranked universe. Areas of concern include balance sheet strength (25.3) and institutional flow (29.2), which score below median versus the broader universe. Based on the latest XBRL financial filings (Q3 2026), InnovAge Holding Corp. reports quarterly revenue of $251.9M, net income of $-29.5M, free cash flow of $14.5M. Top institutional holders of INNV by reported 13-F value include BlackRock,, Coliseum Capital Management,, VANGUARD CAPITAL MANAGEMENT, based on the most recent SEC filings. INNV trades on the Nasdaq exchange and files with the SEC under CIK 1834376. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate INNV daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for InnovAge Holding Corp. directly from SEC EDGAR. InnovAge Holding Corp.'s 13F Pro composite quality score has ranged between 33 and 49 since 2024, currently 46.1 — an improving long-term trajectory across 15 quarterly and live scoring snapshots.

Fun facts about InnovAge Holding Corp.

Quirks, history, and lore behind INNV — the kind of stuff that makes a stock memorable.

  • 1
    The Basics
    U.S. healthcare services company · small-cap · listed on Nasdaq · headquartered in Colorado.
  • 2
    The Numbers
    Annual revenue in the low hundreds of millions of dollars, serving a population that is both elderly and low-income — a dual-eligibility sweet spot that drives its entire business model.
  • 3
    The History
    Founded in the early 2000s, it went public around 2021 and built its model around a federal program designed to keep frail seniors out of nursing homes.
  • 4
    The Secret
    It operates under the PACE model — Program of All-inclusive Care for the Elderly — where it receives capitated payments to manage every aspect of a participant's medical and social needs.
  • 5
    The Lore
    The company faced federal and state regulatory scrutiny in the early 2020s over care quality concerns, sending its stock on a dramatic slide shortly after its IPO honeymoon ended.
  • 6
    The Giveaway
    It's the largest pure-play PACE provider in the U.S., keeping senior participants living independently by wrapping medical, social, and day-center care into one all-inclusive program — ticker: INNV.
▶ Think you know your stocks? Play the Daily Ticker

Revenue

Q3 2026

$251.9M

Net Income

Q3 2026

$-29.5M

Free Cash Flow

Q3 2026

$14.5M

D/E Ratio

Q3 2026

0.25

Revenue & Net Income

Earnings Per Share

Key Financials Over Time

Export Financial Table · Pro+

Revenue

+24.1% YoY
$853.7MFY 2025
FY22 $698.6MFY23 $688.1MFY25 $853.7M

Net Income

+25.5% YoY
$-30.3MFY 2025
FY22 $-6.5MFY23 $-40.7MFY25 $-30.3M

Operating Income

+39.7% YoY
$-29.8MFY 2025
FY22 $-4.4MFY23 $-49.4MFY25 $-29.8M

EPS (Diluted)

+26.7% YoY
$-0.22FY 2025
FY22 $-0.05FY23 $-0.30FY25 $-0.22

Total Assets

-7.1% YoY
$526.9MFY 2025
FY22 $555.6MFY23 $567.4MFY25 $526.9M

Total Debt

-15.4% YoY
$62.3MFY 2025
FY22 $77.4MFY23 $73.6MFY25 $62.3M

Op. Cash Flow

+62.4% YoY
$32.9MFY 2025
FY22 $27.3MFY23 $20.2MFY25 $32.9M

Get alerted when INNV's score changes

Free account: watchlist tracking, the daily AI brief, and the AI screener.

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Available Research

13F Pro tracks comprehensive data for InnovAge Holding Corp. including:

SEC EDGAR filings (10-K, 10-Q, 8-K)
XBRL financial facts (revenue, EPS, margins)
Insider transactions (Form 4)
Institutional 13F holdings
Quality rankings (32 signals)
AI analyst debates & daily meetings
Historical financial trends
Peer comparison & sector analysis

Put INNV on your watchlist

Track score changes the day InnovAge Holding Corp. files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.

View Pricing

Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Is INNV a good stock to buy?

13F Pro's AI-powered analysis of InnovAge Holding Corp. (INNV) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Healthcare sector (listed on Nasdaq). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for INNV are available on the INNV stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing.

Which hedge funds own INNV?

Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling INNV. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of InnovAge Holding Corp.'s investment landscape.